A behavioral economics perspective on the COVID-19 vaccine amid public mistrust

Abstract The COVID-19 vaccine development, testing, and approval processes have moved forward with unprecedented speed in 2020. Although several vaccine candidates have shown promising results in clinical trials, resulting in expedited approval for public use from the U.S. Food and Drug Administrati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational behavioral medicine 2021-03, Vol.11 (3), p.821-825
Hauptverfasser: Saleska, Jessica Londeree, Choi, Kristen R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 825
container_issue 3
container_start_page 821
container_title Translational behavioral medicine
container_volume 11
creator Saleska, Jessica Londeree
Choi, Kristen R
description Abstract The COVID-19 vaccine development, testing, and approval processes have moved forward with unprecedented speed in 2020. Although several vaccine candidates have shown promising results in clinical trials, resulting in expedited approval for public use from the U.S. Food and Drug Administration, recent polls suggest that Americans strongly distrust the vaccine and its approval process. This mistrust stems from both the unusual speed of vaccine development and reports about side effects. This article applies insights from behavioral economics to consider how the general public may make decisions around whether or not to receive a future COVID-19 vaccine in a context of frequent side effects and preexisting mistrust. Three common cognitive biases shown to influence human decision-making under a behavioral economics framework are considered: confirmation bias, negativity bias, and optimism bias. Applying a behavioral economics framework to COVID-19 vaccine decision-making can elucidate potential barriers to vaccine uptake and points of intervention for clinicians and public health professionals. Several COVID-19 vaccines are being rapidly developed in response to the 2020 coronavirus pandemic. Studies show that the vaccines are safe and provide some protection against COVID-19. In an emergency situation like a pandemic, vaccine makers can apply for an emergency approval from the government to distribute the vaccine. Several companies plan to do this. However, polls show that Americans are worried about the speed of vaccine development and approval. They are also worried about vaccine side effects. Worries like these may lead people to decide not to get the COVID-19 vaccine. If enough people decide they do not want the vaccine, it will be difficult to slow down the pandemic. Behavioral economics is the study of human decision-making. This article discusses how behavioral economics can be used to understand how people may intuitively think about the decision to get a COVID-19 vaccine. Humans can sometimes have errors in judgment (called “cognitive biases”). By identifying these errors as they relate to the COVID-19 vaccine, we can prepare health care providers and health officials to help people make fully informed decisions about the vaccine.
doi_str_mv 10.1093/tbm/ibaa147
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8033588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A671552965</galeid><oup_id>10.1093/tbm/ibaa147</oup_id><sourcerecordid>A671552965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-3b8ed293752030d38809646c2b76991501147a35b0d40dfb054f77e0217428ec3</originalsourceid><addsrcrecordid>eNp9kc9r2zAUx0VZWUPb0-5DMNiluJEs69dlELJuDRRyaXsVsvzcaMSWsZxA__u9kqy0MCodJKTP--p99SXkC2fXnFkxn-puHmvveaVPyIwrLgprFPuEe6NsoTRXZ-Qy5z8MR6VKrvlnciaEVlWlxIysF7SGjd_HNPothZD61MWQ6QBjHiBMcQ809XTaAF2uH1c_C27p3ocQe6C-iw0ddvU2BtrFPI27PF2Q09ZvM1we13Py8Ovmfnlb3K1_r5aLuyJIpqdC1Aaa0gotSyZYI4xhVlUqlLVW1nLJOBryQtasqVjT1kxWrdbAsP-qNBDEOflx0MX3O2gC9BMacMMYOz8-u-Sje3_Tx417SntnmBDSGBT4dhB48ltwsW8TYgFtBLfAX5OytEoidf0fCmcD-E2phzbi-buCq0NBGFPOI7SvLXHmXhJzmJg7Job017cuXtl_-SDw_QCk3fCh0l-xA51T</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A behavioral economics perspective on the COVID-19 vaccine amid public mistrust</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Saleska, Jessica Londeree ; Choi, Kristen R</creator><creatorcontrib>Saleska, Jessica Londeree ; Choi, Kristen R</creatorcontrib><description>Abstract The COVID-19 vaccine development, testing, and approval processes have moved forward with unprecedented speed in 2020. Although several vaccine candidates have shown promising results in clinical trials, resulting in expedited approval for public use from the U.S. Food and Drug Administration, recent polls suggest that Americans strongly distrust the vaccine and its approval process. This mistrust stems from both the unusual speed of vaccine development and reports about side effects. This article applies insights from behavioral economics to consider how the general public may make decisions around whether or not to receive a future COVID-19 vaccine in a context of frequent side effects and preexisting mistrust. Three common cognitive biases shown to influence human decision-making under a behavioral economics framework are considered: confirmation bias, negativity bias, and optimism bias. Applying a behavioral economics framework to COVID-19 vaccine decision-making can elucidate potential barriers to vaccine uptake and points of intervention for clinicians and public health professionals. Several COVID-19 vaccines are being rapidly developed in response to the 2020 coronavirus pandemic. Studies show that the vaccines are safe and provide some protection against COVID-19. In an emergency situation like a pandemic, vaccine makers can apply for an emergency approval from the government to distribute the vaccine. Several companies plan to do this. However, polls show that Americans are worried about the speed of vaccine development and approval. They are also worried about vaccine side effects. Worries like these may lead people to decide not to get the COVID-19 vaccine. If enough people decide they do not want the vaccine, it will be difficult to slow down the pandemic. Behavioral economics is the study of human decision-making. This article discusses how behavioral economics can be used to understand how people may intuitively think about the decision to get a COVID-19 vaccine. Humans can sometimes have errors in judgment (called “cognitive biases”). By identifying these errors as they relate to the COVID-19 vaccine, we can prepare health care providers and health officials to help people make fully informed decisions about the vaccine.</description><identifier>ISSN: 1869-6716</identifier><identifier>EISSN: 1613-9860</identifier><identifier>DOI: 10.1093/tbm/ibaa147</identifier><identifier>PMID: 33764463</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adult ; COVID-19 Pandemic ; COVID-19 Vaccines ; Decision Making ; Economics, Behavioral ; Health Knowledge, Attitudes, Practice ; Humans ; United States</subject><ispartof>Translational behavioral medicine, 2021-03, Vol.11 (3), p.821-825</ispartof><rights>Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2021</rights><rights>Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>COPYRIGHT 2021 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-3b8ed293752030d38809646c2b76991501147a35b0d40dfb054f77e0217428ec3</citedby><cites>FETCH-LOGICAL-c507t-3b8ed293752030d38809646c2b76991501147a35b0d40dfb054f77e0217428ec3</cites><orcidid>0000-0001-5453-1091</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,1583,27915,27916</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33764463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saleska, Jessica Londeree</creatorcontrib><creatorcontrib>Choi, Kristen R</creatorcontrib><title>A behavioral economics perspective on the COVID-19 vaccine amid public mistrust</title><title>Translational behavioral medicine</title><addtitle>Transl Behav Med</addtitle><description>Abstract The COVID-19 vaccine development, testing, and approval processes have moved forward with unprecedented speed in 2020. Although several vaccine candidates have shown promising results in clinical trials, resulting in expedited approval for public use from the U.S. Food and Drug Administration, recent polls suggest that Americans strongly distrust the vaccine and its approval process. This mistrust stems from both the unusual speed of vaccine development and reports about side effects. This article applies insights from behavioral economics to consider how the general public may make decisions around whether or not to receive a future COVID-19 vaccine in a context of frequent side effects and preexisting mistrust. Three common cognitive biases shown to influence human decision-making under a behavioral economics framework are considered: confirmation bias, negativity bias, and optimism bias. Applying a behavioral economics framework to COVID-19 vaccine decision-making can elucidate potential barriers to vaccine uptake and points of intervention for clinicians and public health professionals. Several COVID-19 vaccines are being rapidly developed in response to the 2020 coronavirus pandemic. Studies show that the vaccines are safe and provide some protection against COVID-19. In an emergency situation like a pandemic, vaccine makers can apply for an emergency approval from the government to distribute the vaccine. Several companies plan to do this. However, polls show that Americans are worried about the speed of vaccine development and approval. They are also worried about vaccine side effects. Worries like these may lead people to decide not to get the COVID-19 vaccine. If enough people decide they do not want the vaccine, it will be difficult to slow down the pandemic. Behavioral economics is the study of human decision-making. This article discusses how behavioral economics can be used to understand how people may intuitively think about the decision to get a COVID-19 vaccine. Humans can sometimes have errors in judgment (called “cognitive biases”). By identifying these errors as they relate to the COVID-19 vaccine, we can prepare health care providers and health officials to help people make fully informed decisions about the vaccine.</description><subject>Adult</subject><subject>COVID-19 Pandemic</subject><subject>COVID-19 Vaccines</subject><subject>Decision Making</subject><subject>Economics, Behavioral</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Humans</subject><subject>United States</subject><issn>1869-6716</issn><issn>1613-9860</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9r2zAUx0VZWUPb0-5DMNiluJEs69dlELJuDRRyaXsVsvzcaMSWsZxA__u9kqy0MCodJKTP--p99SXkC2fXnFkxn-puHmvveaVPyIwrLgprFPuEe6NsoTRXZ-Qy5z8MR6VKrvlnciaEVlWlxIysF7SGjd_HNPothZD61MWQ6QBjHiBMcQ809XTaAF2uH1c_C27p3ocQe6C-iw0ddvU2BtrFPI27PF2Q09ZvM1we13Py8Ovmfnlb3K1_r5aLuyJIpqdC1Aaa0gotSyZYI4xhVlUqlLVW1nLJOBryQtasqVjT1kxWrdbAsP-qNBDEOflx0MX3O2gC9BMacMMYOz8-u-Sje3_Tx417SntnmBDSGBT4dhB48ltwsW8TYgFtBLfAX5OytEoidf0fCmcD-E2phzbi-buCq0NBGFPOI7SvLXHmXhJzmJg7Job017cuXtl_-SDw_QCk3fCh0l-xA51T</recordid><startdate>20210301</startdate><enddate>20210301</enddate><creator>Saleska, Jessica Londeree</creator><creator>Choi, Kristen R</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5453-1091</orcidid></search><sort><creationdate>20210301</creationdate><title>A behavioral economics perspective on the COVID-19 vaccine amid public mistrust</title><author>Saleska, Jessica Londeree ; Choi, Kristen R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-3b8ed293752030d38809646c2b76991501147a35b0d40dfb054f77e0217428ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>COVID-19 Pandemic</topic><topic>COVID-19 Vaccines</topic><topic>Decision Making</topic><topic>Economics, Behavioral</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Humans</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saleska, Jessica Londeree</creatorcontrib><creatorcontrib>Choi, Kristen R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational behavioral medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saleska, Jessica Londeree</au><au>Choi, Kristen R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A behavioral economics perspective on the COVID-19 vaccine amid public mistrust</atitle><jtitle>Translational behavioral medicine</jtitle><addtitle>Transl Behav Med</addtitle><date>2021-03-01</date><risdate>2021</risdate><volume>11</volume><issue>3</issue><spage>821</spage><epage>825</epage><pages>821-825</pages><issn>1869-6716</issn><eissn>1613-9860</eissn><abstract>Abstract The COVID-19 vaccine development, testing, and approval processes have moved forward with unprecedented speed in 2020. Although several vaccine candidates have shown promising results in clinical trials, resulting in expedited approval for public use from the U.S. Food and Drug Administration, recent polls suggest that Americans strongly distrust the vaccine and its approval process. This mistrust stems from both the unusual speed of vaccine development and reports about side effects. This article applies insights from behavioral economics to consider how the general public may make decisions around whether or not to receive a future COVID-19 vaccine in a context of frequent side effects and preexisting mistrust. Three common cognitive biases shown to influence human decision-making under a behavioral economics framework are considered: confirmation bias, negativity bias, and optimism bias. Applying a behavioral economics framework to COVID-19 vaccine decision-making can elucidate potential barriers to vaccine uptake and points of intervention for clinicians and public health professionals. Several COVID-19 vaccines are being rapidly developed in response to the 2020 coronavirus pandemic. Studies show that the vaccines are safe and provide some protection against COVID-19. In an emergency situation like a pandemic, vaccine makers can apply for an emergency approval from the government to distribute the vaccine. Several companies plan to do this. However, polls show that Americans are worried about the speed of vaccine development and approval. They are also worried about vaccine side effects. Worries like these may lead people to decide not to get the COVID-19 vaccine. If enough people decide they do not want the vaccine, it will be difficult to slow down the pandemic. Behavioral economics is the study of human decision-making. This article discusses how behavioral economics can be used to understand how people may intuitively think about the decision to get a COVID-19 vaccine. Humans can sometimes have errors in judgment (called “cognitive biases”). By identifying these errors as they relate to the COVID-19 vaccine, we can prepare health care providers and health officials to help people make fully informed decisions about the vaccine.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>33764463</pmid><doi>10.1093/tbm/ibaa147</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-5453-1091</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1869-6716
ispartof Translational behavioral medicine, 2021-03, Vol.11 (3), p.821-825
issn 1869-6716
1613-9860
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8033588
source MEDLINE; Oxford University Press Journals All Titles (1996-Current)
subjects Adult
COVID-19 Pandemic
COVID-19 Vaccines
Decision Making
Economics, Behavioral
Health Knowledge, Attitudes, Practice
Humans
United States
title A behavioral economics perspective on the COVID-19 vaccine amid public mistrust
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T02%3A28%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20behavioral%20economics%20perspective%20on%20the%20COVID-19%20vaccine%20amid%20public%20mistrust&rft.jtitle=Translational%20behavioral%20medicine&rft.au=Saleska,%20Jessica%20Londeree&rft.date=2021-03-01&rft.volume=11&rft.issue=3&rft.spage=821&rft.epage=825&rft.pages=821-825&rft.issn=1869-6716&rft.eissn=1613-9860&rft_id=info:doi/10.1093/tbm/ibaa147&rft_dat=%3Cgale_pubme%3EA671552965%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33764463&rft_galeid=A671552965&rft_oup_id=10.1093/tbm/ibaa147&rfr_iscdi=true